Takata T, Ito H, Ogawa I, Miyauchi M, Ijuhin N, Nikai H
Clinical Laboratory, Hiroshima University School of Dentistry, Japan.
Virchows Arch A Pathol Anat Histopathol. 1991;419(3):177-82. doi: 10.1007/BF01626345.
Six cases of spindle cell squamous carcinoma (SCSC) of the oral cavity were studied clinicopathologically, immunohistochemically and ultrastructurally to summarize the clinicopathological features of this rare neoplasm and to discuss the debatable histogenesis of the sarcomatoid component and the differential diagnosis of SCSC. The mean age of the patients was 72 years and the female to male ratio was 1:2. Four of them had a history of irradiation for pre-existing squamous cell carcinoma. One patient died of SCSC. While clinical and histological prognostic factors of SCSC could not be determined, it was shown that radical surgery resulted in good prognosis. The epithelial nature of the sarcomatoid component of SCSC was clearly revealed by a combination of immunohistochemical staining for keratins and electron microscopic demonstration of tonofilament-like filaments and/or desmosome-like structures. Together with electron microscopic evaluation of the tumour cells, immunohistochemical characterization of tumour cells using antibodies to keratin, vimentin, glial fibrillary acidic protein and S-100 protein is very helpful in differentiating SCSC from true spindle cell sarcoma, melanoma and malignant myoepithelioma. In the immunohistochemical differential diagnosis of SCSC, it is important to remember that SCSC should not be ruled out of the differential diagnosis by a positive reaction for vimentin in sarcomatoid tumour cells. Absence of staining for keratin in the sarcomatoid tumour cells does not always exclude SCSC, because some SCSCs show immunoreactivity of keratin in their sarcomatoid components only with some anti-keratin antibodies. Different kinds of anti-keratin antibodies should be applied in the differential diagnosis of SCSC.
对6例口腔梭形细胞鳞状癌(SCSC)进行了临床病理、免疫组织化学及超微结构研究,以总结这种罕见肿瘤的临床病理特征,并探讨肉瘤样成分有争议的组织发生及SCSC的鉴别诊断。患者的平均年龄为72岁,男女比例为1:2。其中4例有既往鳞状细胞癌放疗史。1例患者死于SCSC。虽然无法确定SCSC的临床和组织学预后因素,但显示根治性手术可带来良好预后。通过角蛋白免疫组织化学染色及张力丝样细丝和/或桥粒样结构的电镜证实相结合,清楚地揭示了SCSC肉瘤样成分的上皮性质。连同肿瘤细胞的电镜评估,使用角蛋白、波形蛋白、胶质纤维酸性蛋白和S-100蛋白抗体对肿瘤细胞进行免疫组织化学特征分析,对鉴别SCSC与真性梭形细胞肉瘤、黑色素瘤及恶性肌上皮瘤非常有帮助。在SCSC的免疫组织化学鉴别诊断中,重要的是要记住,肉瘤样肿瘤细胞波形蛋白阳性反应不应排除SCSC的鉴别诊断。肉瘤样肿瘤细胞角蛋白染色阴性并不总是排除SCSC,因为一些SCSC仅在其肉瘤样成分中与某些抗角蛋白抗体显示角蛋白免疫反应性。在SCSC的鉴别诊断中应应用不同种类的抗角蛋白抗体。